{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:29:03Z","timestamp":1786422543518,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07251-4","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:52:00Z","timestamp":1784051520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-associated acute pancreatitis in paediatric versus adult reports: a disproportionality analysis using FAERS"],"prefix":"10.1007","volume":"185","author":[{"given":"Annelien","family":"Vantrappen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-8727","authenticated-orcid":false,"given":"Nadir","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9882-8273","authenticated-orcid":false,"given":"Karen","family":"van Hoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3090-9755","authenticated-orcid":false,"given":"Pauline","family":"De Bruyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9921-5105","authenticated-orcid":false,"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"7251_CR1","doi-asserted-by":"publisher","unstructured":"Ahmed F, Abu-El-Haija M (2025) Acute pancreatitis in children: it\u2019s not just a simple attack. Gastroenterology. W.B. Saunders, pp 572\u201384.  https:\/\/doi.org\/10.1053\/j.gastro.2025.04.001","DOI":"10.1053\/j.gastro.2025.04.001"},{"key":"7251_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2023.1231320","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Mao W, Liu D, Hu B, Lin X, Ran J et al (2023) Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS). Front Pharmacol 14:14. https:\/\/doi.org\/10.3389\/fphar.2023.1231320","journal-title":"Front Pharmacol"},{"issue":"15","key":"7251_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1526924815151008","volume":"2014","author":"MR Jones","year":"2015","unstructured":"Jones MR, Morgan Hall O, Kaye AM, David KA (2015) Drug-induced acute pancreatitis: a review. Ochsner J 2014(15):45\u201351. https:\/\/doi.org\/10.1177\/1526924815151008","journal-title":"Ochsner J"},{"issue":"3","key":"7251_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/MPG.0000000000000417","volume":"59","author":"VD Morinville","year":"2014","unstructured":"Morinville VD, Lowe ME, Ahuja M, Barth B, Bellin MD, Davis H et al (2014) Design and implementation of INSPPIRE. J Pediatr Gastroenterol Nutr 59(3):360\u2013364. https:\/\/doi.org\/10.1097\/MPG.0000000000000417","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7251_CR5","unstructured":"Santhi Swaroop Vege M (2025) Etiology of acute pancreatitis [Internet]. Available from:  https:\/\/www.uptodate.com\/contents\/etiology-of-acute-pancreatitis. Accessed 7 May 2026"},{"issue":"6","key":"7251_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.pan.2020.07.008","volume":"20","author":"M Abu-El-Haija","year":"2020","unstructured":"Abu-El-Haija M, Hornung L, Lin TK, Nathan JD, Thompson T, Vitale DS et al (2020) Drug induced pancreatitis is the leading known cause of first attack acute pancreatitis in children. Pancreatology 20(6):1103\u20131108. https:\/\/doi.org\/10.1016\/j.pan.2020.07.008","journal-title":"Pancreatology"},{"key":"7251_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1564127","author":"H Xie","year":"2025","unstructured":"Xie H, Jiang L, Peng J, Hu H, Han M, Zhao B (2025) Drug-induced pancreatitis: a real-world analysis of the FDA adverse event reporting system and network pharmacology. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2025.1564127","journal-title":"Front Pharmacol"},{"issue":"4","key":"7251_CR8","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MPG.0b013e318228574e","volume":"53","author":"HX Bai","year":"2011","unstructured":"Bai HX, Ma MH, Orabi AI, Park A, Latif SU, Bhandari V et al (2011) Novel characterization of drug-associated pancreatitis in children. J Pediatr Gastroenterol Nutr 53(4):423\u2013428. https:\/\/doi.org\/10.1097\/MPG.0b013e318228574e","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"7251_CR9","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1053\/j.gastro.2018.12.043","volume":"156","author":"A Uc","year":"2019","unstructured":"Uc A, Husain SZ (2019) Pancreatitis in children. Gastroenterology 156(7):1969\u20131978. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.043","journal-title":"Gastroenterology"},{"issue":"3","key":"7251_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cpt.3139","volume":"115","author":"D Li","year":"2024","unstructured":"Li D, Wang H, Qin C, Du D, Wang Y, Du Q et al (2024) Drug-induced acute pancreatitis: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database. Clin Pharmacol Ther 115(3):535\u2013544. https:\/\/doi.org\/10.1002\/cpt.3139","journal-title":"Clin Pharmacol Ther"},{"key":"7251_CR11","doi-asserted-by":"publisher","unstructured":"Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V et al (2024) The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacoVigilance (READUS-PV): explanation and elaboration. Drug Saf 47(6):585\u2013599.  https:\/\/doi.org\/10.1007\/s40264-024-01423-7","DOI":"10.1007\/s40264-024-01423-7"},{"key":"7251_CR12","doi-asserted-by":"publisher","unstructured":"Uc A, Cress GA, Wang F, Abu-El-Haija M, Ellery KM, Fishman DS et al (2022) Analysis of INSPPIRE-2 cohort: risk factors and disease burden in children with acute recurrent or chronic pancreatitis. J Pediatr Gastroenterol Nutr 75(5):643\u2013649.  https:\/\/doi.org\/10.1097\/MPG.0000000000003590","DOI":"10.1097\/MPG.0000000000003590"},{"key":"7251_CR13","unstructured":"Ema (2013) Committee for medicinal products for human use (CHMP) paediatric committee (PDCO) Guideline on pharmaceutical development of medicines for paediatric use Guideline on pharmaceutical development of medicines for paediatric use [Internet]. Available from: www.ema.europa.eu. Accessed 7 May 2026"},{"key":"7251_CR14","unstructured":"US food and drug administration (2023) What is a serious adverse event? URL: https:\/\/www.fda.gov\/safety\/reporting-serious-problems-fda\/what-serious-adverse-event. Accessed 7 Apr 2026"},{"issue":"9","key":"7251_CR15","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S1470-2045(17)30424-2","volume":"18","author":"BO Wolthers","year":"2017","unstructured":"Wolthers BO, Frandsen TL, Baruchel A, Attarbaschi A, Barzilai S, Colombini A et al (2017) Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study. Lancet Oncol 18(9):1238\u20131248. https:\/\/doi.org\/10.1016\/S1470-2045(17)30424-2","journal-title":"Lancet Oncol"},{"issue":"3","key":"7251_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJM199101173240301","volume":"324","author":"K Butler","year":"1991","unstructured":"Butler K, Hussen R, Balis F, Brouwers P, Eddy J, El-Amih D et al (1991) Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 324(3):137\u2013144. https:\/\/doi.org\/10.1056\/NEJM199101173240301","journal-title":"N Engl J Med"},{"key":"7251_CR17","unstructured":"EMA. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/post-authorisation\/pharmacovigilance-post-authorisation\/good-pharmacovigilance-practices-gvp. Accessed 25 Mar 2026"},{"issue":"58","key":"7251_CR18","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1002\/jcph.1284","volume":"1","author":"J van den Anker","year":"2018","unstructured":"van den Anker J, Reed MD, Allegaert K, Kearns GL (2018) Developmental changes in pharmacokinetics and pharmacodynamics. J Clin Pharmacol 1(58):S10-25. https:\/\/doi.org\/10.1002\/jcph.1284","journal-title":"J Clin Pharmacol"},{"key":"7251_CR19","doi-asserted-by":"publisher","unstructured":"Kearns G, Abdel-Rahman S, Alander S, Blavey D, Leeder JS, Kauffman R (2003) Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med 349(12):1157\u20131167.  https:\/\/doi.org\/10.1056\/NEJMra0","DOI":"10.1056\/NEJMra0"},{"key":"7251_CR20","doi-asserted-by":"publisher","unstructured":"Gkrinia EMM, Belan\u010di\u0107 A, Jankovi\u0107 SM (2026) Putting FAERS data into perspective: cautionary considerations for comparative safety assessment. Eur J Hosp Pharm. https:\/\/doi.org\/10.1136\/ejhpharm-2026-005052","DOI":"10.1136\/ejhpharm-2026-005052"},{"key":"7251_CR21","doi-asserted-by":"publisher","unstructured":"Massironi S, Fanetti I, Vigan\u00f2 C, Pirola L, Fichera M, Cristoferi L et al (2022) Systematic review\u2014pancreatic involvement in inflammatory bowel disease. Aliment Pharmacol Ther 1478\u20131491.  https:\/\/doi.org\/10.1111\/apt.16949. Wiley","DOI":"10.1111\/apt.16949"},{"key":"7251_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ph17121654","volume":"17","author":"HT Yal\u00e7\u0131n","year":"2024","unstructured":"Yal\u00e7\u0131n HT, Yal\u00e7\u0131n N, Ceulemans M, Allegaert K (2024) Drug safety during breastfeeding: a comparative analysis of 2 FDA adverse event reports and LactMed\u00ae. Pharmaceuticals. 17:17. https:\/\/doi.org\/10.3390\/ph17121654","journal-title":"Pharmaceuticals."}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07251-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:50:00Z","timestamp":1786420200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07251-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7251"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07251-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9794114\/v1","asserted-by":"object"}]},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Karel Allegaert is member of the editorial board of European Journal of Paediatrics. He has not taken part in the review or selection process of this article. None of the authors has a conflict of interest relevant to the content of this article.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"574"}}